Shulman Joseph's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 14, 2025
- Accession no.
- 0001104659-25-014259
- Filed
- Feb 14, 2025
- Trade date
- Feb 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $26.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shulman JosephCIK 0001909855 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | SSaleDisposed | −462 | $56.39 | −$26,052.18 | 5,619 | Direct | |
| Feb 12, 2025 | Common Stock | SSaleDisposed | −7 | $57.09 | −$399.63 | 5,612 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.